Diagnostics product maker Qiagen NV announces offering of new common shares
By APTuesday, September 22, 2009
Qiagen NV announces offering of new common shares
Netherlands-based diagnostic products maker Qiagen NV announced on Tuesday a placement of 27.5 million newly issued common shares in an international offering.
Shares will be offered to institutional investors outside the United States and as a registered offering in the United States, the company said in a statement. The company also will grant underwriters an option to purchase up to 4.125 million additional shares to cover overallotments.
Deutsche Bank, Goldman Sachs International and JPMorgan will act as joint global coordinators and joint bookrunners. The order book will open Wednesday.
The company said in a statement it will use the proceeds for its acquisition of DxS Ltd., possible future acquisitions, balance sheet strengthening and general corporate purposes.
Company shares fell 2 percent, or 49 cents, to $21.88 Tuesday in after-hours trading.
